Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
Sarcopenia and frailty: new challenges for clinical practice
Richard Dodds1, Avan Aihie Sayer2
1Academic Geriatric Medicine, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton UK.
Sarcopenia (age-related muscle loss) and frailty increase with age, sharing physical symptoms like low muscle mass. Interventions include exercise, supplements, and addressing life-course factors.
Area of Science:
- Gerontology
- Muscle physiology
- Aging research
Background:
- Sarcopenia, the loss of muscle mass and function, and frailty, a state of increased vulnerability, are common in aging.
- These conditions share overlapping physical phenotypes, including reduced muscle mass, grip strength, and gait speed.
- These physical markers are linked to various aging outcomes and are clinically assessable.
Purpose of the Study:
- To summarize the current understanding of sarcopenia and frailty in aging.
- To highlight the overlap in clinical assessment measures.
- To review current and emerging intervention strategies and preventative approaches.
Main Methods:
- Literature review of sarcopenia and frailty in aging populations.
- Analysis of shared clinical assessment metrics.
- Synthesis of evidence on interventions and life-course aetiology.
Main Results:
- Sarcopenia and frailty are prevalent age-related conditions with overlapping physical characteristics.
- Resistance exercise shows benefits, but feasibility can be a limitation.
- Ongoing research explores pharmacological and nutritional interventions, alongside life-course approaches for prevention.
Conclusions:
- Sarcopenia and frailty represent significant challenges in aging populations.
- A multi-faceted approach combining exercise, potential medical/nutritional therapies, and life-course strategies is crucial for management and prevention.
- Further research is needed to optimize interventions and preventative measures across the lifespan.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pharmacodynamics in Geriatric Patients: Effects of Age
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

